2024-27410. Organ Procurement and Transplantation: Implementation of the HIV Organ Policy Equity (HOPE) Act

Table 1—Summary of Impacts of the Final Rule

[Millions of constant 2023 dollars]

Category	Primary estimate	Low estimate	High estimate	Dollar year or unit	Discount rate (%)	Time horizon	Notes
BENEFITS
Annualized monetized benefits	$612	$381	$858	2023	2	2025-2034	Increased life expectancy for organ transplant recipients; improved quality of life for kidney transplant recipients; time savings from fewer kidney dialysis visits.
Annualized quantified, but non-monetized, benefits	72	64	81	People affected	2	2025-2034	Improved quality of life for liver transplant recipients.
Unquantified benefits						2025-2034	Time savings for caregivers; cost savings for transplant centers from removing the research and institutional review board requirements; difficult-to-quantify benefits associated with stigma-reducing terminology.
COSTS
Annualized monetized costs	83	73	92	2023	2	2025-2034	Medical expenditures associated with transplantation; time spent by transplant centers to read and understand the final rule, review policies and procedures, and train staff.
TRANSFERS
Annualized monetized transfers	30	24	37	2023	2	2025-2034	Shift in expenditures from kidney dialysis to kidney transplantation.
NET BENEFITS
Annualized monetized net benefits	530	301	772	2023	2	2025-2034
Note: primary, low, and high estimates correspond to the mean, 5th percentile, and 95th percentile of the outcomes of a Monte Carlo simulation.